Less than half of the children aged 0-14 who have TB are diagnosed – so they never even start treatment.
Academic rigor, journalistic flair
Articles on Tuberculosis (TB)
Displaying 1 - 20 of 163 articles
Progress in many areas of TB control stalled or reversed mainly because of the COVID-19 pandemic and the recent geo-political situations.
BCG has been around for a century, but it’s still being studied for its ‘non-specific effects’.
Ashkenazi Jews are significantly more susceptible to a rare genetic disorder known as Gaucher disease.
We need a combination of new approaches to reduce age disparate sex. And we need new technologies to protect young women.
An expert in the lives and works Brontës argues that it’s time for a radical change in the way we think about Emily Brontë’s death.
Intensified efforts to obtain funding are urgently required to mitigate and reverse the negative impacts of the COVID-19 pandemic on TB.
Addressing the noncommunicable disease pandemic can also mitigate challenges facing people living with HIV and complement efforts against TB.
There are several reasons that TB patients don’t or can’t adhere to their treatment.
Some vulnerable populations may have fallen through the cracks despite efforts to improve access to HIV services during the pandemic in Nigeria.
The overcrowded conditions of prisons make them a high-risk environment for the spread of infectious diseases such as TB.
Outpatient visits, screening and diagnostic services, and child immunisation were particularly negatively affected.
Beitbridge and Musina are two border towns in Zimbabwe and South Africa that see many migrants pass through – with different health needs.
To understand the perceptions of TB patients about their quality of life, it’s useful to have a comparison with “apparently healthy” people.
As antibiotics lose their power to treat some forms of TB, interest in the antibacterial powers of curdlan is rising.
We expected to find that screening everybody for TB would identify individuals not yet diagnosed, and treating them quickly would reduce the prevalence of TB in the community.
An inhaled COVID-19 vaccine would go directly to where the body would use it: the mucosal surface of the airways. This could mean less waste and more benefit, lower costs and reduced side-effects.
The risk of dying changes over the course of a lifetime. Very high at birth, it falls and then gradually rises again… except for a peak after adolescence. Why such a statistical anomaly?
India’s recent Tuberculosis survey showed worse results than expected.
Unless special attention is given to conflict and HIV the war will undermine the achievement of the 2030 goals to end AIDS, discrimination, and new infections.
Top contributors
-
Director of Global Health & Professor, McGill University
-
Assistant Professor, Africa Health Research Institute (AHRI)
-
Associate Professor, Melbourne Health
-
Faculty Member, Africa Health Research Institute; Associate professor, UCL
-
Head of the Centre of Excellence for Biomedical TB Research, University of the Witwatersrand
-
Associate Professor in Paediatrics and Child Health, University of Sydney
-
Honorary Research Associate, Centre for Infectious Disease Epidemiology and Research, University of Cape Town
-
Associate Professor, SARChI Research Chair in Mycobactomics, Stellenbosch University
-
Head of the Immunology Research Group at the Division of Molecular Biology & Human Genetics, Department of Biomedical Sciences, Faculty of Medicine & Health Sciences, Stellenbosch University
-
Head of the Division of Pulmonology, University of Cape Town
-
Infectious Diseases Physician and Senior Clinical Lecturer, Liverpool School of Tropical Medicine and Honorary Research Associate, University of Liverpool
-
Associate Professor, Pharmaceutical Sciences, University of the Western Cape
-
Faculty Member, Africa Health Research Institute; Wellcome Trust Senior Research Fellow, UCL
-
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
-
Professor of International Health at LSHTM and Member of Faculty, Africa Health Research Institute (AHRI)
